These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19957330

  • 21. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W, Fan H, He X, Zhang J, Xie W.
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [Abstract] [Full Text] [Related]

  • 22. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Morita M, Nakao M, Baba H.
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
    Sasaki J, Konishi F, Kawamura YJ, Kai T, Takata O, Tsukamoto T.
    Int J Cancer; 2006 Jul 01; 119(1):80-3. PubMed ID: 16432831
    [Abstract] [Full Text] [Related]

  • 24. Hypomethylation trends in the intergenic region of the imprinted IGF2 and H19 genes in cloned cattle.
    Curchoe CL, Zhang S, Yang L, Page R, Tian XC.
    Anim Reprod Sci; 2009 Dec 01; 116(3-4):213-25. PubMed ID: 19282114
    [Abstract] [Full Text] [Related]

  • 25. Examination of IGF2 and H19 loss of imprinting in bladder cancer.
    Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS.
    Cancer Res; 2007 Nov 15; 67(22):10753-8. PubMed ID: 18006818
    [Abstract] [Full Text] [Related]

  • 26. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, Feinberg AP.
    Cancer Res; 2001 Jul 01; 61(13):4947-50. PubMed ID: 11431321
    [Abstract] [Full Text] [Related]

  • 27. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
    Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF.
    Prostate; 2011 Nov 01; 71(15):1621-30. PubMed ID: 21432864
    [Abstract] [Full Text] [Related]

  • 28. Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
    Sparago A, Cerrato F, Riccio A.
    Clin Epigenetics; 2018 Nov 01; 10():23. PubMed ID: 29484033
    [Abstract] [Full Text] [Related]

  • 29. Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting.
    Pan Y, He B, Lirong Z, Nie Z, Chen L, Gu L, Hoffman AR, Wang S, Hu J.
    Oncol Rep; 2013 Oct 01; 30(4):1814-22. PubMed ID: 23900345
    [Abstract] [Full Text] [Related]

  • 30. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR, He XB, Yang YH, Xie W.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb 01; 20(1):31-4. PubMed ID: 12579496
    [Abstract] [Full Text] [Related]

  • 31. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekström TJ.
    Oncogene; 1995 Jul 20; 11(2):221-9. PubMed ID: 7624139
    [Abstract] [Full Text] [Related]

  • 32. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
    Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF, Hoffman AR.
    Genomics; 2000 Mar 01; 64(2):132-43. PubMed ID: 10729220
    [Abstract] [Full Text] [Related]

  • 33. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer.
    Tanaka K, Shiota G, Meguro M, Mitsuya K, Oshimura M, Kawasaki H.
    Oncology; 2001 Mar 01; 60(3):268-73. PubMed ID: 11340379
    [Abstract] [Full Text] [Related]

  • 34. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
    Takano Y, Shiota G, Kawasaki H.
    Oncology; 2000 Sep 01; 59(3):210-6. PubMed ID: 11053988
    [Abstract] [Full Text] [Related]

  • 35. Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.
    Li T, Chen H, Li W, Cui J, Wang G, Hu X, Hoffman AR, Hu J.
    Hum Mol Genet; 2014 Jan 01; 23(1):117-28. PubMed ID: 23962719
    [Abstract] [Full Text] [Related]

  • 36. Dissociation of IGF2 and H19 imprinting in human brain.
    Pham NV, Nguyen MT, Hu JF, Vu TH, Hoffman AR.
    Brain Res; 1998 Nov 09; 810(1-2):1-8. PubMed ID: 9813220
    [Abstract] [Full Text] [Related]

  • 37. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.
    Murrell A, Ito Y, Verde G, Huddleston J, Woodfine K, Silengo MC, Spreafico F, Perotti D, De Crescenzo A, Sparago A, Cerrato F, Riccio A.
    PLoS One; 2008 Mar 26; 3(3):e1849. PubMed ID: 18365005
    [Abstract] [Full Text] [Related]

  • 38. Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism.
    Tserga A, Binder AM, Michels KB.
    FASEB J; 2017 Dec 26; 31(12):5149-5158. PubMed ID: 28778973
    [Abstract] [Full Text] [Related]

  • 39. Loss of imprinting in hepatoblastoma.
    Rainier S, Dobry CJ, Feinberg AP.
    Cancer Res; 1995 May 01; 55(9):1836-8. PubMed ID: 7728748
    [Abstract] [Full Text] [Related]

  • 40. Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
    Hofmann WK, Takeuchi S, Frantzen MA, Hoelzer D, Koeffler HP.
    Exp Hematol; 2002 Apr 01; 30(4):318-23. PubMed ID: 11937266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.